Kodiak Sciences Reports Q3 2026 Net Loss of $66.2 Million, $88.7 Million in Cash

Kodiak Sciences reported a third-quarter 2026 net loss of $66.2 million, or $1.05 per share, compared with a $61.5 million loss a year earlier. Research and development expenses increased to $58.3 million, while cash and cash equivalents stood at $88.7 million at quarter-end. The company also raise…